Trend toward self-management fuels growth of diabetes device sales
With the increasing trend of self-management and the rising awareness around the diabetes disease state within developing countries, blood glucose meters can be utilized to aid in adjustment of therapeutic regimen in response to blood glucose values and to help patients adjust their dietary intake, physical activity and insulin doses to improve glycaemic control on a regular basis.
This and several other factors are covered in the latest Research and Marekts report focused on diabetes care devices.
The global diabetes care devices market is expected to grow at a CAGR of 5.3% from 2017 to 2022 to reach $26.7 billion Research and Markets reported in its "Diabetes Care Devices Market - Global Opportunity Analysis and Industry Forecast (2017-2022)" report released Thursday.
Increasing prevalence of diabetes, technological advancements, rise in obese population, sedentary lifestyle and improper diet and increasing need for faster and safer diagnosis and treatment of diabetes are the key market drivers covered in the report.
However, high cost associated with diagnosis and treatment, reimbursement issues for new technologies and lack of awareness about the timely care of the disease for its better management are the major pain points, restraining the adoption of the diabetes care devices.
This and several other factors are covered in the latest Research and Marekts report focused on diabetes care devices.
The global diabetes care devices market is expected to grow at a CAGR of 5.3% from 2017 to 2022 to reach $26.7 billion Research and Markets reported in its "Diabetes Care Devices Market - Global Opportunity Analysis and Industry Forecast (2017-2022)" report released Thursday.
Increasing prevalence of diabetes, technological advancements, rise in obese population, sedentary lifestyle and improper diet and increasing need for faster and safer diagnosis and treatment of diabetes are the key market drivers covered in the report.
However, high cost associated with diagnosis and treatment, reimbursement issues for new technologies and lack of awareness about the timely care of the disease for its better management are the major pain points, restraining the adoption of the diabetes care devices.